Mai Capital Management Inmune Bio, Inc. Transaction History
Mai Capital Management
- $9.3 Billion
- Q1 2024
A detailed history of Mai Capital Management transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Mai Capital Management holds 181,410 shares of INMB stock, worth $1.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
181,410
Previous 98,012
85.09%
Holding current value
$1.6 Million
Previous $1.1 Million
93.2%
% of portfolio
0.02%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding INMB
# of Institutions
57Shares Held
2.88MCall Options Held
44.6KPut Options Held
3.5K-
Vanguard Group Inc Valley Forge, PA541KShares$4.77 Million0.0% of portfolio
-
Black Rock Inc. New York, NY240KShares$2.12 Million0.0% of portfolio
-
Rhenman & Partners Asset Management Ab Stockholm, V7178KShares$1.57 Million0.2% of portfolio
-
Geode Capital Management, LLC Boston, MA171KShares$1.51 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny159KShares$1.4 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $158M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...